May 5 |
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
|
May 3 |
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
|
May 3 |
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
|
May 3 |
Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know
|
May 3 |
Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript
|
May 3 |
Kymera Therapeutics Inc (KYMR) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
|
May 2 |
Kymera Therapeutics GAAP EPS of -$0.69 beats by $0.04, revenue of $10.3M misses by $2.75M
|
May 2 |
Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
|
May 1 |
Kymera Therapeutics Q1 2024 Earnings Preview
|
Apr 26 |
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|